Thursday, August 8, 2013

MDL Panel Grants Transfer in Effexor Litigation and Two Others

The Judicial Panel on Multidistrict Litigation granted three Motions to Centralize and denied eight Motions to Centralize in its July 2013 Hearing Session.

Motion granted:

MDL No. 2458 - IN RE: Effexor (Venlafaxine Hydrochloride) Products Liability Litigation (before Judge Rufe in the Eastern District of Pennsylvania)

MDL No. 2455 - IN RE: Stericycle, Inc., Steri-Safe Contract Litigation (before Judge Shadur in the Northern District of Illinois)

MDL No. 2454 - IN RE: Franck's Lab, Inc., Products Liability Litigation (before Judge Engelhardt in the Eastern District of Louisiana)

Motion denied:

MDL No. 2469 - IN RE: Capatriti Brand Olive Oil Marketing and Sales Practices Litigation

MDL No. 2467 - IN RE: Bank of America, N.A., Mortgage Corporation Force-Placed Hazard Insurance Litigation

MDL No. 2466 - IN RE: Wells Fargo Bank, N.A., Mortgage Corporation Force-Placed Hazard Insurance Litigation

MDL No. 2465 - IN RE: JPMorgan Chase Bank, N.A., Mortgage Corporation Force-Placed Hazard Insurance Litigation

MDL No. 2464 - IN RE: HSBC Mortgage Corporation Force-Placed Hazard Insurance Litigation

MDL No. 2463 - IN RE: Fresh Dairy Products Antitrust Litigation (No. II)

MDL No. 2453 - IN RE: Adderall XR (Amphetamine/Dextroamphetamine) Marketing, Sales Practices and Antitrust Litigation

MDL No. 2456 - IN RE: Kashi Company Marketing and Sales Practices Litigation

 

PM

http://lawprofessors.typepad.com/civpro/2013/08/mdl-panel-grants-transfer-in-effexor-litigation-and-two-others.html

Mass Torts, MDLs, Recent Decisions | Permalink

Comments

Post a comment